Konferenzen zum Thema Pharmakologie und Arzneimittelentwicklung in Großbritannien

Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Organisatoren können kostenlos ihre Konferenzankündigungen veröffentlichen.

1.
 
Adverse Drug Reactions, Drug Interactions and Pharmacovigilance Course
ID
722697
Termin
09. Mai 2016 - 13. Mai 2016
Ort
Oxford, Großbritannien
Kontakt
Course Administrator;     Tel.: [01865 286955];     Email: expther@conted.ox.ac.uk
2.
 
2nd Annual Formulation & Drug Delivery Congress 2016
ID
748339
Termin
18. Mai 2016 - 19. Mai 2016
Ort
London, Großbritannien
Zusammenfassung
Oxford Global are delighted to announce the 2nd Annual Formulation & Drug Delivery Congress, 18 – 19 May 2016, London, UK. Over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will discuss over 40 presentations and case studies focused on the key issues in biologics and small molecule drug formulation and delivery.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
Biologics, Formulation, Drug Delivery, Biologics, Small Molecule, Nanoparicle,
3.
 
Training — Rheumatoid Arthritis: Current Treatment & Management
ID
791171
Beginn
19. Mai 2016
Ort
London, Großbritannien
Zusammenfassung
This intensive one-day programme will focus on current patient management techniques for rheumatoid arthritis (RA). Delegates will be introduced to current strategies and the issues associated with rheumatology clinical trials.
Kontakt
Linda Merritt;     Tel.: [01727 809917];     Email: courses@healthcare-ed.com
Themen
Structural Anatomy of Joints, Aetiology and Pathogenesis of Rheumatoid Arthritis, Clinical Features and Diagnosis of Rheumatoid Disease, Current Patient Symptom Management and Disease Modification
4.
 
Molecular Diagnostics World Summit 2016
ID
758910
Termin
19. Mai 2016 - 20. Mai 2016
Ort
London, Großbritannien
Zusammenfassung
The global molecular diagnostics market is predicted to reach $8 billion by 2018. This market is highly influenced by the raise of infectious diseases such as TB, HIV etc, antimicrobial resistance and other factors. 80% of the market are shared between Europe and America and remaining 20% between Rest of the World. To provide efficient treatment and disease management there is an urgent need for rapid and more efficient diagnostics. In terms of technology PCR based diagnostics are rapidly growing and possess the major market shares. NGS, POC, Microarrays and others form the rest of the market. Molecular Diagnostics market comprises of instruments, reagents, software and end user services which has a great future and growth by 2018. Thus, Molecular Diagnostics World Summit 2016, conference offers a rare opportunity to its participants to understand and learn from top experts in the Molecular Microbiology and Diagnostics field and to share ideas and develop new business collaborations. The conference will also provide a platform to discuss the current vital issues, market assessment, commercialization and globalization.
Verwandte Fachgebiete
5.
 
Immunogenicity
ID
793256
Termin
13. Jun 2016 - 14. Jun 2016
Ort
London, Großbritannien
Zusammenfassung
Immunogenicity of an antigen is frequently encountered in the context of vaccine development, an area of intense interest currently due to the emergence or re-emergence of infectious pathogens with the potential for worldwide spread. With the global vaccine market expected to reach $84.44 billion by 2022, now is the time engage with industry experts to addresses the real challenges with immunogenicity including assay assessment, the role of aggregation, the introduction of nanobodies and many more!
Kontakt
Anna Serazetdinova;     Tel.: [+44 20 7827 6093];     Email: aserazetdinova@smi-online.co.uk
Themen
immunology, immunogenicity, pathology, biosimilars, nanobodies, ADCs, aggregation
6.
 
2PV2016 — 2nd Pharmacovigilance Conference 2016
ID
802958
Termin
14. Jun 2016 - 15. Jun 2016
Ort
London, Großbritannien
Zusammenfassung
RecunnectLtd takes the pleasure to invite professionals involved in pharmacovigilance, risk assessment and management, clinical research, data analysis and related fields for a two day conference on Pharmacovigilance to enable them to gain a vantage point in the contemporary pharma industry by ingraining themselves with updates on regulatory trends in inspections of signal detection, post authorisation safety studies, optimal use of social media in pharmacovigilance, data mining technology, outsourcing Pharmacovigilance and strategic pharmacovigilance pre and post product life cycle.
Kontakt
Sarika Sareen;     Tel.: [2071129183];     Email: marketing@recunnect.net
Themen
risk assessment risk management clinical research data analysis pharma Conference Pharmacovigilance Pharmacogenomics/Drug Product Safety Drug Development, Information and Clinical Data Management Clinical Pharmacology Clinical Safety Periodical Safety update Report Risk Management, Research and Development Quality Assurance Patient Safety Safety Surveillance Outcomes Research Data Analysis Epidemiology Medical Affairs Regulatory Affairs and Compliance Information Technology Sales and Marketing
7.
 
Pharmacovigilance Europe 2016
ID
759939
Termin
21. Jun 2016 - 22. Jun 2016
Ort
London, Großbritannien
Zusammenfassung
The  Pharmacovigilance Europe 2016  conference will participants an opportunity and a platform to share experiences with the likeminded individuals in the field. The conference will also provide an insight into the complexities and challenges impacting public safety and risk management, focusing mainly on drugs, biologics and medical devices and the future of PV in the globalization era.
8.
 
Lyophilisation Europe
ID
799402
Termin
04. Jul 2016 - 05. Jul 2016
Ort
London, Großbritannien
Zusammenfassung
SMi is thrilled to announce the return of its 4th annual conference, Lyophilisation Europe, taking place on 4th and 5th July in London, UK. With the rising risk of contamination and the need for improved formulation methods of biological products, robust capabilities in lyophilisation and freeze drying methods have become critical for process efficiency and commercial success whilst maintaining drug quality and stability. Innovation and efficiency is requested at every level making Lyophilisation Europe 2016, the perfect platform to strengthen knowledge in key principles such as PAT and QbD, whilst staying at the forefront of technological breakthroughs to adapt to a competitive growing industry.
Kontakt
Teri Arri;     Tel.: [+442078276000];     Email: tarri@smi-online.co.uk
Themen
lyophilisation, quality by design, freeze drying, scale-up, validation, spray drying, Process Analytical Techniques, PAT, robustness, stability, delivery, optimisation, protein stabilisation, design strategies, maintenance, automatic loading and unloading, lyophilization, qbd, protein, optimization, aseptic, fill/finish, temperature, drying, powder, nucleation, sterilization, injectables, thaw, storage, crystallization, formulation, parenteral, lyophilization
9.
 
CSDD-2016 — II International Conference on Clinical Sciences and Drug Discovery
ID
790778
Termin
27. Jul 2016 - 29. Jul 2016
Ort
Dundee, Scotland, Großbritannien
Zusammenfassung
United Scientific group had successfully completed its first conference International conference on Clinical Sciences and Drug Discovery, in Baltimore USA, during November 02-04, 2015 (CSDD-2015). With this enthusiasm and prodigious success, we are proudly announcing the second conference International conference on Clinical Sciences and Drug Discovery -2016, Dundee, Scotland during July 27-29, 2016 (CSDD-2016) with a theme Drug discovery and development to clinical trials. Our focus lies on the translation of academic research findings into industry-driven drug development, Features including a world-class program of invited speakers from industry and academia, oral and poster presentations from submitted abstracts maintaining the same level of talks. Throughout the course of the three-day conference, you will get an exclusive opportunity to network and be involved in inspiring and interesting discussions of scientists and researchers on Antimicrobials: Bacterial, Fungal, Viral, Protozoal, Antineoplastic, Endocrinology and Metabolism, Hematological, CNS & ANS, Cardio-Vascular System, Respiratory, Nano therapeutics, Computer Aided Drug Designing, Structural Biology and many more research topics. The organizing committee is confident that participants will benefit from the high value scientific program. We welcome all the researchers to join us for these 3 days of stimulating discussions, knowledge sharing and networking event.
Kontakt
CSDD-2016 Committee;     Tel.: [408-426-4833];     Email: drugdiscovery@uniscigroup.org
Themen
Infectious: Bacteria, Fungi, Viruses, Protozoa, Neoplastic: Cancers, Tumours, and Lymphomas, Endocrinologic and Metabolic, Hematological, CNS & ANS, Cardiovascular, Respiratory, Immunological, Nano-Bio Therapeutics, Computer Aided Drug Design, Structural Biology, Medicinal Chemistry & Imaging
10.
 
Chemical biology approaches to assessing and modulating mitochondria
ID
776865
Termin
26. Sep 2016 - 27. Sep 2016
Ort
The Royal Society at Chicheley Hall, Buckinghamshi, Großbritannien
Zusammenfassung
Mitochondria are central to many current biomedical problems. In these, variations in chemical processes are critical, but progress in understanding these and in developing therapies has been hampered by lack of methods to measure and manipulate mitochondrial 'chemistry'. This meeting will explore the interface of chemical biology and mitochondrial studies to open up new avenues for research and therapeutic interventions.
Kontakt
Naomi Asantewa-Sechereh;     Tel.: [+442074512515];     Email: kavli.events@royalsociety.org
Themen
redox signalling, Reactive oxygen species (ROS), oxidative damage, mitochondria, mitochondrial therapies
Verwandte Fachgebiete
11.
 
14th Annual Pharma IT Congress
ID
787569
Termin
28. Sep 2016 - 29. Sep 2016
Ort
London, Großbritannien
Zusammenfassung
Oxford Global are proud to present the 14th Annual Pharmaceutical IT Congress, taking place on 28 – 29 September 2016 in London, UK. This highly established event will focus on exciting Big Data implementation case studies, novel research results in translational informatics, updates in data management for Real-World Evidence and novel IT solutions. The pharmaceutical IT industry represents a complex area of research that is under continuous pressure to develop novel solutions to improve its performance. Thanks to recent advancements in cloud computing solutions, Real-World Data and analytics, the industry is flourishing.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
Over 200 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions Over 40 presentations and case studies focusing on the key developments in Big Data, Translational Informatics, Data Management for Real-World Evidence and IT Solutions Including 4 interactive streams: - Utilising Big Data In R&D - Translational Informatics - Data Management For Real-World Evidence - Novel IT Solutions
Verwandte Fachgebiete
12.
 
The Structure of Clinical Trials and Experimental Therapeutics - University of Oxford
ID
749648
Termin
10. Okt 2016 - 14. Okt 2016
Ort
Oxford, Großbritannien
Kontakt
Course Administrator;     Tel.: [01865 286955];     Email: expther@conted.ox.ac.uk
Themen
pharmacology, drug development, clinical trials, experimental therapeutics, oxford
13.
 
Training — Diabetes: An Overview
ID
791221
Beginn
13. Okt 2016
Ort
London, Großbritannien
Zusammenfassung
This introductory course provides an overview of the causes, mechanisms and management of diabetes from both a clinical management and a drug development perspective. Our expert speaker will introduce the pathogenesis of the disease and discuss current prevention and treatment options as well as the complications associated with diabetes. The complex inter-relationship with dyslipidaemias, hypertension, obesity and subsequent cardiovascular risk will be examined in some detail.
Kontakt
Linda Merritt;     Tel.: [01727 809917];     Email: courses@healthcare-ed.com
Themen
Clinical presentation and classification, Pathophysiology of T2 diabetes, Treatment options, Micro and macrovascular complications, Prevention of type 2 diabetes – the evidence
14.
 
International Paediatric Pharmaceutical Care Masterclass
ID
800036
Termin
13. Okt 2016 - 15. Okt 2016
Ort
London, Großbritannien
Zusammenfassung
This is a highly practical masterclass designed by the expert pharmaceutical team at Evelina Children’s Hospital London, part of Guy’s and St Thomas’ NHS Foundation Trust. The masterclass combines case studies, lectures, role plays and patient case reviews at hospital bed sides.
Verwandte Fachgebiete
15.
 
Keystone Symposia: Translational Vaccinology for Global Health
ID
806790
Termin
26. Okt 2016 - 30. Okt 2016
Ort
London, Großbritannien
Zusammenfassung
The time required to launch new global health vaccines is too long and the late failure rate is unsustainably high. Key barriers include insufficient diversity and quality of preclinical concepts and candidates, immunobiological ignorance, and a lack of understanding of correlates or mechanisms of protection. Root causes include siloed science and linear thinking; poor integration across the discovery/development/delivery ecosystem; and slow entry and limited throughput in early human proof of concept testing. This Keystone Symposia meeting aims to bring together those pioneering novel, creative solutions to these problems of global vaccine discovery and development across the academic/biotech/product development partner/pharma spectrum.
Kontakt
Attendee Services;     Tel.: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Themen
Vaccines Immunology Infectious Diseases Global Health
Verwandte Fachgebiete
16.
 
Training — Immunotherapies: An Introductory Overview
ID
791263
Beginn
03. Nov 2016
Ort
London, Großbritannien
Zusammenfassung
This one-day programme provides an introduction to immunotherapies. Immunotherapies are an increasingly important treatment method for a wide range of diseases. This training is developed specifically for pharmaceutical industry personnel and provides a thorough foundation to the subject applicable across therapy areas. It is ideal for individuals with little understanding of immunotherapies and equally beneficial to those with existing basic knowledge enabling further insight to the subject through detailed presentations and discussion with Healthcare’s expert physician faculty.
Kontakt
Linda Merritt;     Tel.: [01727 809917];     Email: courses@healthcare-ed.com
Themen
The immune system – a guide, Introduction to immunotherapies, What goes wrong!, Examples in practice, The future
17.
 
Gynaecological Oncology — An Update on Topical Issues within Gynaecology Oncology
ID
805520
Beginn
09. Nov 2016
Ort
South Kensington, London, Großbritannien
Kontakt
Conference Team;     Tel.: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Themen
Update in Gynaecology Oncology Surgery, Long term GI effects of cancer treatment; Genetics and BRCA testing in Gynaecology Oncology; Update in Gynaecology Clinical Oncology and Nurse led Clinics in Endometrial cancer, A Patient’s perspective, Supporting Women on aspects of motherhood and parenting, Update in Gynaecology Medical Oncology and Nurse led Chemotherapy Clinics, Sexuality post treatment for Gynaecological cancers, Summary and questions session.
Verwandte Fachgebiete

Alle Konferenzen in Großbritannien anzeigen.

LYOPHILIZATION USA
PAIN THERAPEUTICS

Interessant...

You can advertise your event or services in this space.

Stand vom 30. Oktober 2077